Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$372.46+1.98 (+0.53%)
Close on Nov 16, 2026Market cap $30.24BP/E 30.6Yield 0.77%
Labcorp total assets
Total assets on the balance sheet at the end of each period.
Labcorp's total assets was $18.92B at Sep 30, 2026. For fiscal 2025 it was $18.39B, up 0.1% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is $20.39B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.39B | +0.1% |
| FY2024 | Dec 31, 2024 | $18.38B | +9.9% |
| FY2023 | Dec 31, 2023 | $16.73B | -17.0% |
| FY2022 | Dec 31, 2022 | $20.16B | -1.1% |
| FY2021 | Dec 31, 2021 | $20.39B | +1.6% |
| FY2020 | Dec 31, 2020 | $20.07B | +11.2% |
| FY2019 | Dec 31, 2019 | $18.05B | +11.5% |
| FY2018 | Dec 31, 2018 | $16.19B | -2.9% |
| FY2017 | Dec 31, 2017 | $16.67B | +17.0% |
| FY2016 | Dec 31, 2016 | $14.25B | +1.0% |
| FY2015 | Dec 31, 2015 | $14.10B | +93.2% |
| FY2014 | Dec 31, 2014 | $7.30B | +4.8% |
| FY2013 | Dec 31, 2013 | $6.97B | +2.5% |
| FY2012 | Dec 31, 2012 | $6.80B | +11.2% |
| FY2011 | Dec 31, 2011 | $6.11B | -1.2% |
| FY2010 | Dec 31, 2010 | $6.19B | +27.9% |
| FY2009 | Dec 31, 2009 | $4.84B | +3.6% |
| FY2008 | Dec 31, 2008 | $4.67B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $18.92B | +3.6% |
| Q2 FY2026 | Jun 30, 2026 | $18.53B | +2.6% |
| Q1 FY2026 | Mar 31, 2026 | $19.09B | +8.4% |
| Q4 FY2025 | Dec 31, 2025 | $18.39B | +0.1% |
| Q3 FY2025 | Sep 30, 2025 | $18.26B | -1.9% |
| Q2 FY2025 | Jun 30, 2025 | $18.06B | +8.1% |
| Q1 FY2025 | Mar 31, 2025 | $17.60B | +6.5% |
| Q4 FY2024 | Dec 31, 2024 | $18.38B | +9.9% |
| Q3 FY2024 | Sep 30, 2024 | $18.61B | +10.2% |
| Q2 FY2024 | Jun 30, 2024 | $16.71B | -5.7% |
| Q1 FY2024 | Mar 31, 2024 | $16.53B | -18.2% |
| Q4 FY2023 | Dec 31, 2023 | $16.73B | -17.0% |
| Q3 FY2023 | Sep 30, 2023 | $16.89B | -14.8% |
| Q2 FY2023 | Jun 30, 2023 | $17.72B | -13.2% |
| Q1 FY2023 | Mar 31, 2023 | $20.20B | -2.5% |
| Q4 FY2022 | Dec 31, 2022 | $20.16B | -1.1% |
| Q3 FY2022 | Sep 30, 2022 | $19.83B | -5.0% |
| Q2 FY2022 | Jun 30, 2022 | $20.40B | -0.1% |
| Q1 FY2022 | Mar 31, 2022 | $20.73B | +1.5% |
| Q4 FY2021 | Dec 31, 2021 | $20.39B | +1.6% |
| Q3 FY2021 | Sep 30, 2021 | $20.87B | +11.3% |
| Q2 FY2021 | Jun 30, 2021 | $20.42B | +14.4% |
| Q1 FY2021 | Mar 31, 2021 | $20.42B | +18.0% |
| Q4 FY2020 | Dec 31, 2020 | $20.07B | +11.2% |
| Q3 FY2020 | Sep 30, 2020 | $18.74B | +5.0% |
| Q2 FY2020 | Jun 30, 2020 | $17.85B | +0.6% |
| Q1 FY2020 | Mar 31, 2020 | $17.30B | +1.9% |
| Q4 FY2019 | Dec 31, 2019 | $18.05B | +11.5% |
| Q3 FY2019 | Sep 30, 2019 | $17.85B | +7.1% |
| Q2 FY2019 | Jun 30, 2019 | $17.74B | +7.5% |
| Q1 FY2019 | Mar 31, 2019 | $16.97B | +0.8% |
| Q4 FY2018 | Dec 31, 2018 | $16.19B | -2.9% |
| Q3 FY2018 | Sep 30, 2018 | $16.66B | -0.2% |
| Q2 FY2018 | Jun 30, 2018 | $16.50B | +10.7% |
| Q1 FY2018 | Mar 31, 2018 | $16.83B | +16.7% |
| Q4 FY2017 | Dec 31, 2017 | $16.67B | +17.0% |
| Q3 FY2017 | Sep 30, 2017 | $16.69B | – |
| Q2 FY2017 | Jun 30, 2017 | $14.90B | – |
| Q1 FY2017 | Mar 31, 2017 | $14.43B | – |
| Q4 FY2016 | Dec 31, 2016 | $14.25B | – |
See a number that looks wrong?